1. How to use GuruFocus - Tutorials
  2. What Is in the GuruFocus Premium Membership?
  3. A DIY Guide on How to Invest Using Guru Strategies
Holly LaFon
Holly LaFon
Articles (7041) 

Invesco European Growth Fund Comments on MorphoSys

September 05, 2013 | About:

MorphoSys (NYSE:MOR) is a German biotechnology company with proprietary technology to develop human antibodies for specific diseases. Over the quarter, the company signed two licensing deals (with GlaxoSmithKline PLC and Celgene Corp., not held by the fund) for its proprietary compounds, providing outside validation for its technology as well as upfront cash and future royalty payments.

From Invesco European Fund's second quarter commentary 2013.


Rating: 4.0/5 (3 votes)

Comments

Please leave your comment:


GuruFocus has detected 5 Warning Signs with Morgan Stanley $MOR.
More than 500,000 people have already joined GuruFocus to track the stocks they follow and exchange investment ideas.

User Generated Screeners


pbarker465 Values & Good Interest Cover
pbarker46E10 & High Interest coverage
doug.quailConsistent Growth
yukondeltagEV-EBITDA Space
akcapitalSmall Cap - Payout Yield
Funnyman1Cash Flow
brettHigh Quality
kw1123S&P Consistent Growth
musselmantbob
pbarker46Low 3 Hist Values
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
FEEDBACK